NICA (NICA) News
Follow NICA (NICA) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 9 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Nanologica resolves rights issue of about SEK 110.5 million
EQUITY | Oct 23, 2026, 06:36 AM UTC
M
Nanologica Launches SEK 110.5M Rights Issue With SEK 10M Option
The issue is covered 77.6% by commitments and a guarantee intention. Full take-up implies dilution of up to about 66.7%, or 69.6% including fees.
EQUITY | Oct 23, 2026, 06:06 AM UTC
M
Nanologica Plans SEK 110.5M Rights Issue, Names CEO
Nanologica intends a rights issue of approximately SEK 110.5 million to fund its updated growth strategy and path to profitability. Mark Quick is set to become CEO, pending an exemption.
EQUITY | Oct 23, 2026, 05:37 AM UTC
L
Nanologica (Q2 review): Stockpiling powder, awaiting conversion
Redeye’s analyst just published a Research Update on Nanologica.Click here to read the articleMake sure to add Nanologica to your Watchlist at Redeye and our analysts will notify you if anything relevant happens regardin
EQUITY | Sep 03, 2026, 10:46 AM UTC
L
Nanologica (Q2 initial take): Softer Syntagon sales
Nanologica (Q2 initial take): Softer Syntagon sales
EQUITY | Aug 31, 2026, 08:34 AM UTC
L
Life science firm Nanologica's Q2 sales surge on Syntagon acquisition
Life science firm Nanologica's Q2 sales surge on Syntagon acquisition
MNA | Aug 31, 2026, 06:21 AM UTC
L
Nanologica reports Q2 operating loss of SEK 18.1 million
Nanologica posted a Q2 operating loss of SEK 18.1 million.
EARNINGS | Aug 31, 2026, 06:13 AM UTC
L
NICA outlook improves on Syntagon acquisition sales growth
NICA says strong sales growth tied to the Syntagon acquisition, plus stable silica production, drives an improved outlook.
EARNINGS | Aug 31, 2026, 06:12 AM UTC
L
Nanologica AB interim report for Q2 2026
Nanologica AB (publ) published its interim report for Q2 2026.
EQUITY | Aug 31, 2026, 06:10 AM UTC